Showing results (51-60 of 214) with videos related to
Sort By:
Pageof 22
Cancer Treatment Reviews|September 10, 2008
Exploitation of protein kinase C: a useful target for cancer therapyAshhar S Ali, Shadan Ali, Bassel F El-Rayes, et al.Journal of Cellular Physiology|June 13, 2012
The role of cancer stem cells and miRNAs in defining the complexities of brain metastasisAshhar S Ali, Aamir Ahmad, Shadan Ali, et al.Cancers|August 27, 2021
Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAsYiwei Li, Mohammed Najeeb Al Hallak, Philip A Philip, et al.Anticancer Research|July 31, 2012
Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinomaKhaldoun Almhanna, Bassel El-Rayes, Seema Sethi, et al.Cancer Letters|January 21, 2012
RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cellsShadan Ali, Aamir Ahmad, Amro Aboukameel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Phase I study of bryostatin 1 and gemcitabineBasil F El-Rayes, Shirish Gadgeel, Anthony F Shields, et al.Molecular Cancer Therapeutics|June 21, 2008
Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancerShadan Ali, Sanjeev Banerjee, Aamir Ahmad, et al.Journal of Cellular Physiology|January 4, 2012
Inactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K-Ras transgenic mouse model of pancreatic cancerShadan Ali, Sanjeev Banerjee, Farah Logna, et al.Mini Reviews in Medicinal Chemistry|April 10, 2010
MDM2 inhibitors for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, Khaldoun Almhanna, et al.Cancer Research|August 6, 2009
Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cellsYiwei Li, Timothy G VandenBoom, Dejuan Kong, et al.Pageof 22